hotspot -WSS

hotspot

author：entertainment 2025-08-28 13:05:47 - browse：251

Photography of the US department of health and human services in Silver Spring MD — Manuel Balce Ceneta/AP

An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

Triple-check your data or we’ll reject your device, the FDA warned.

The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Telehealth startups are trying to fill the menopause care vacuum

leisure time

WSS

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

US jobless claims fall again as labor market continues to flash strength

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Supreme Court to hear if Covid misinformation is protected speech

focus

hotspot

focus

What does generative AI mean for health care? We asked experts

WuXi Biologics execs register to lobby as Congress comes for the company

As demand for Covid shots wanes, Moderna seeks its next success

Oak Street deal isn't the answer to health care's woes

Bright Health sells Medicare Advantage business to Molina

Hormonal contraceptives don’t actually treat endometriosis

Medical records are filled with copy

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Apple is now the first public company to be valued at $3 trillion

Stanford president’s abrupt resignation sparks debate

focus

Are infertility treatments 'essential' during the Covid

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Caribou posts encouraging results on off

Ripples from Flovent's discontinuation is killing children with asthma

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

explore

leisure time

explore

focus